Mika Nakamae

Notable effects of angiotensin II receptor blocker, valsartan, on acute cardiotoxic changes after standard chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisolone

Hirohisa Nakamae, Kei Tsumura, Yoshiki Terada et al. · Cancer · 2005 · 243 citations · Full text

Medicine, Oncology, Pharmacology +16

Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation

Hirohisa Nakamae, Takahisa Yamane, Taro Hasegawa et al. · American Journal of Hematology · 2006 · 107 citations

Medicine, Hematology, Immunology +16

Different immunoprofiles in patients with chronic myeloid leukemia treated with imatinib, nilotinib or dasatinib

Yoshiki Hayashi, Hirohisa Nakamae, Takako Katayama et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2012 · 60 citations

Life Sciences, Immunology, Pharmacology +15

An enterococcal phage-derived enzyme suppresses graft-versus-host disease

Kosuke Fujimoto, Tetsuya Hayashi, Mako Yamamoto et al. · Nature · 2024 · 42 citations · Full text

Life Sciences, Immunology, Microbiology +17

Feasibility of Reduced-Intensity Cord Blood Transplantation as Salvage Therapy for Graft Failure: Results of a Nationwide Survey of Adult Patients

Fusako Waki, Kazuhiro Masuoka, Takahiro Fukuda et al. · Biology of Blood and Marrow Transplantation · 2010 · 40 citations · Full text

Medicine, Hematology, Oncology +17